Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8228678 | 1.00 | ALDH1A1 (0.34) | ALDH1A1SMN1; SMN2KDM4ECYP2C19NPSR1 | |
| Hydrochloric Acid SCHEMBL10437891 | 0.97 | ALDH1A1 (0.33) | ALDH1A1SMN1; SMN2KDM4ECYP2C19 | |
| SCHEMBL2342427 | 0.97 | — | — | |
| Acetic Acid SCHEMBL11142798 | 0.95 | FFAR3 (0.37) | ALDH1A1SMN1; SMN2KDM4ECYP2C19USP2 | |
| SCHEMBL8230373 | 0.91 | — | — | |
| SCHEMBL11140873 | 0.86 | KDM4E (0.34) | KDM4ECYP2C19TSHR | |
| SCHEMBL890235 | 0.84 | — | — | |
| Butyric Acid SCHEMBL11144951 | 0.81 | FFAR3 (0.50) | ALDH1A1CYP2C19LMNATSHR | |
| Acetic Acid SCHEMBL27516411 | 0.78 | CYP2C19 (0.39) | ALDH1A1SMN1; SMN2KDM4ECYP2C19USP2 | |
| SCHEMBL16892247 | 0.76 | POLB (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104437621-B | Catalyst system and catalyzing for alkynol hydration reaction synthesis alpha-alcohol ketone | 中国科学院化学研究所 | 2016-07-13 | — | — | CN | claimed |
| CN-104437621-A | Catalytic system for synthesizing alpha-hydroxy ketone by alkynol hydration reaction | CHINESE ACAD INST CHEMISTRY | 2015-03-25 | — | — | CN | claimed |
| WO-2025003023-A1 | METHOD FOR PRODUCING A CARBOXYLIC ACID | EVONIK OPERATIONS GMBH (DE) | 2025-01-02 | — | — | WO | disclosed |
| WO-2023191506-A1 | METHOD FOR PREPARING CHLORINATED POLYVINYL CHLORIDE RESIN COMPOSITION | 한화솔루션 주식회사 | 2023-10-05 | — | — | WO | disclosed |
| CN-116120295-A | N-substituted imidazole formate derivative and application thereof | 成都麻沸散医药科技有限公司 | 2023-05-16 | — | — | CN | disclosed |
| CN-113166303-B | Preparation method of chlorinated polyvinyl chloride resin | 韩华思路信(株) | 2022-12-09 | — | — | CN | disclosed |
| CN-109843940-B | Method for preparing chlorinated vinyl chloride resin | 韩华化学株式会社 | 2022-05-17 | — | — | CN | disclosed |
| EP-3747869-A1 | SUBSTITUTED IMIDAZOLE FORMATE DERIVATIVE AND USE THEREOF | CHENGDU MFS PHARMA. CO., LTD. (CN) | 2020-12-09 | — | — | EP | disclosed |
| US-20200369621-A1 | SUBSTITUTED IMIDAZOLECARBOXYLATE DERIVATIVES AND THE USE THEREOF | CHENGDU MFS PHARMA. CO., LTD. (CN) | 2020-11-26 | — | — | US | disclosed |
| WO-2019149228-A1 | SUBSTITUTED IMIDAZOLE FORMATE DERIVATIVE AND USE THEREOF | 成都安诺晨创医药科技有限公司 | 2019-08-08 | — | — | WO | disclosed |
| CN-104370891-B | A kind of 5-(butylene lactone-3-ethylidene)-2-aminooimidazole quinoline ketone compounds, preparation method and applications | 中国农业大学 | 2016-09-07 | — | — | CN | disclosed |
| US-4374055-A | ODORS, PERFUMES | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1983-02-15 | — | — | US | disclosed |
| US-4359395-A | Process for enhancing the organoleptic properties of perfumed articles using alkyl esters of 1-alkanolyl cycloalkanols | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1982-11-16 | — | — | US | disclosed |
| EP-0006305-B1 | DERIVATIVES OF 4,5-DIHYDRO-4-OXOFURAN-2-CARBOXYLIC ACID, ESPECIALLY FOR USE AS HYPOLIPIDEMIC AGENTS, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM, TETRAHYDROPYRAN-2,3,5-TRIONES USEFUL IN THE PREPARATION OF THE SAID DERIVATIVES AND A PROCESS FOR PREPARING THESE TETRAHYDROPYRAN-2,3,5-TRIONES | AMERICAN HOME PRODUCTS CORPORATION (US) | 1982-08-11 | — | — | EP | disclosed |
| US-4327749-A | Alkyl esters of 1-alkanoyl cycloalkanols, process for preparing same and organoleptic uses thereof | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1982-05-04 | — | — | US | disclosed |
| US-4244958-A | Hypolipidemic derivatives of 4,5-dihydro-4-oxofuran-2-carboxylic acid | AMERICAN HOME PRODUCTS CORPORATION (US) | 1981-01-13 | — | — | US | disclosed |
| WO-1980000025-A1 | DERIVATIVES OF 4,5-DIHYDRO-4-OXOFURAN-2-CARBOXYLIC ACID,PREPARATIONS AND USE THEREOF AND TETRAHYDROPYRAN-2,3,5-TRIONE INTERMEDIATES | AMERICAN HOME PROD (US) | 1980-01-10 | — | — | WO | disclosed |
| EP-0006305-A1 | Derivatives of 4,5-dihydro-4-oxofuran-2-carboxylic acid, especially for use as hypolipidemic agents, processes for their preparation, pharmaceutical compositions comprising them, tetrahydropyran-2,3,5-triones useful in the preparation of the said derivatives and a process for preparing these tetrahydropyran-2,3,5-triones | AMERICAN HOME PRODUCTS CORPORATION (US) | 1980-01-09 | — | — | EP | disclosed |
| US-4169202-A | Process for preparing 4,5-dihydro-4-oxofuran-2-carboxylic acid derivatives | AMERICAN HOME PRODUCTS CORPORATION (US) | 1979-09-25 | — | — | US | disclosed |
| US-4111917-A | POLYURETHANES | W. R. GRACE & CO. (US) | 1978-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200369621-A1 | SUBSTITUTED IMIDAZOLECARBOXYLATE DERIVATIVES AND THE USE THEREOF | SLC6A13, SLC6A11, SLC6A1 | ALDH1A1 396/4885SMN1; SMN2 1497/4885KDM4E 520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.